Dallas-based Susan G. Komen for the Cure has announced that it will award fifty-six grants totaling $55 million to cancer research institutions in 2011.
Approximately 40 percent of the funding will support projects that seek to understand the underlying origins of breast cancer and why it has the capacity to spread throughout the body; 22 percent will support early detection research; and 20 percent will be invested in new treatments. Additional grant money will support projects seeking to overcome disparities in breast cancer outcomes among different population groups, while the remainder will be used to provide fellowship funding to young scientists. Grant recipients include the University of California, San Francisco and Washington University in St. Louis, both of which were awarded $6.5 million to develop new breast cancer treatments.
In addition, the foundation will allocate $3 million in 2011 for patient support conferences and to provide funding for programs focusing on young women, women with metastatic disease, hereditary breast and ovarian cancer, and cancer-related legal issues. "From understanding and treating aggressive diseases like inflammatory breast cancer, to overcoming disparities in care and outcomes, we continue to fund research that tackles the toughest issues in breast cancer," said Komen president Elizabeth Thompson. "Komen has long been known for supporting the most innovative and far-reaching research, and that will continue in 2011 with this exciting slate of research projects."
For a complete list of 2011 grants, visit the Komen for the Cure Web site.